Press "Enter" to skip to content

Niraparib Granted FDA’s Priority Review for Advanced Ovarian Cancer – Targeted Oncology

admin 0

Niraparib Granted FDA’s Priority Review for Advanced Ovarian Cancer  Targeted Oncology

A priority review designation has been granted by the FDA to a supplemental biologics license application for niraparib as a treatment for patients with advanced …

“ovarian cancer” – Google News

(Visited 1 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *